Loading company…
Jiaxing-based ThunderBio Life Science develops in-vitro testing equipment and digital liquid biopsy technology for cancer research.
Established in 2018 and based in Jiaxing, China, ThunderBio has research and development centers in Shenzhen, Jiaxing and Hong Kong. Its founder and CEO, Guohui Zhou, graduated from Hong Kong University. Its products include a digital PCR system, single cell sequencing systems, droplet readers and amplification reagents, used in cancer research, early cancer screening, targeted therapies and antibody screening. In October 2025 the company closed a Series B2 round from new investor Shanghai STVC Group.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in